Blue Jet Healthcare IPO: Bid Date, Price, lot size, Issue Size, Listing Date

Blue Jet Healthcare IPO: The Blue Jet Healthcare IPO is creating a buzz in the financial world as it offers a unique investment opportunity in the pharmaceutical and healthcare sector. As an entirely offer for sale of 2.43 crore shares, this IPO is set to captivate the attention of investors looking for a slice of the pharmaceutical and healthcare ingredient industry. In this blog, we will delve into the details of the Blue Jet Healthcare IPO, the company’s background, its strengths, and what investors can expect from this promising offering.

See Also: Upcoming IPOs

"Exciting news! Stockesta is now on WhatsApp and Telegram Channels 🚀 Subscribe today | Stay updated with the latest IPO insights!" Follow on Whatsapp! and Join Telegram!

Blue Jet Healthcare IPO Overview

The Blue Jet Healthcare IPO opens for subscription from October 25, 2023, and the subscription period extends until October 27, 2023. The anticipated listing date is set for November 6, 2023. Here are some key details in tabular form:

IPO DateOctober 25, 2023 to October 27, 2023
Listing DateNovember 6, 2023
Face Value₹2 per share
Price₹329 to ₹346 per share
Lot Size43 Shares
Total Issue Size₹840.27 crore
Offer for Sale24,285,160 shares of ₹2 (aggregating up to ₹2.4 crore)
Issue TypeBook Built Issue IPO
Listing AtBSE, NSE
Shareholding Pre-Issue173,465,425
Shareholding Post-Issue173,465,425

See Also: IPO GMP Price Today

Blue Jet Healthcare IPO Lot Size

Investors can participate in the Blue Jet Healthcare IPO by bidding for a minimum of 43 shares and in multiples thereof. The table below outlines the minimum and maximum investments allowed for retail investors:

Retail (Min)143₹14,878
Retail (Max)13559₹193,414
S-HNI (Min)14602₹208,292
S-HNI (Max)672,881₹996,826
B-HNI (Min)682,924₹1,011,704

Blue Jet Healthcare IPO Reservation

The IPO reservation breakdown is as follows:

  • QIB Shares Offered: Not more than 50% of the Net Issue
  • Retail Shares Offered: Not less than 35% of the Net Issue
  • NII (HNI) Shares Offered: Not less than 15% of the Net Issue

Blue Jet Healthcare Limited Financial Information

Period Ended30 Jun 202331 Mar 202331 Mar 202231 Mar 2021
Profit After Tax44.12160.03181.59135.79
Net Worth725.68681.49521.54339.82
Amount in ₹ Crore
Blue Jet Healthcare IPO Financial Report Graph

About Blue Jet Healthcare Limited

Blue Jet Healthcare, established in 1968, is a distinguished pharmaceutical and healthcare ingredient company with a rich history in India. The company has a diverse product portfolio that includes:

  1. Contrast Media Intermediates: Used in CT scans and MRIs.
  2. High-Intensity Sweeteners: Including saccharin and its salts, which are artificial sweeteners.
  3. Pharma Intermediates and Active Pharmaceutical Ingredients (API): Vital components in the pharmaceutical manufacturing process.

The company’s global footprint is characterized by its:

  • Process development and production capabilities.
  • Global regulatory support.
  • Collaboration, development, and manufacturing of advanced pharmaceutical intermediates and API.

Blue Jet Healthcare operates three manufacturing facilities in Maharashtra, India, with substantial annual installed capacities as of June 30, 2023.

The core strengths of the company include:

  • A significant manufacturing capacity of contrast media intermediates in India.
  • Niche market positioning with high entry barriers.
  • Long-term relationships and contracts with multinational customers.

Blue Jet Healthcare IPO Objectives

It’s important to note that the proceeds from this IPO will not go to the company; they will be received by the selling shareholders in proportion to the offered shares they sell. This means the IPO is primarily an opportunity for existing shareholders to exit their positions.

Blue Jet Healthcare IPO Registrar

The registrar for the Blue Jet Healthcare IPO is Link Intime India Private Ltd. You can reach them at:

Blue Jet Healthcare IPO Details

Blue Jet Healthcare IPO Lead Managers

The lead managers for this IPO are:

  • Kotak Mahindra Capital Company Limited
  • ICICI Securities Limited
  • J.P. Morgan India Private Limited

In conclusion, the Blue Jet Healthcare IPO presents a unique opportunity for investors to participate in a pharmaceutical and healthcare ingredient company with a rich history and strong market presence. With a diverse product portfolio and significant manufacturing capacity, the company is poised for growth, making this IPO an exciting prospect for potential investors. As always, it’s essential to conduct thorough research and seek financial advice before making any investment decisions.

"Exciting news! Stockesta is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest IPO insights!" Click here!

👉 IPO GMP || IPO News || IPO Details || IPO Review || Join Whatsapp Channel and read news related to IPO on
Disclaimer: The information provided on this website is for informational purposes only and should not be construed as financial or investment advice. Users are advised to do their own research and consult a qualified financial advisor before making any investment decisions.
What is an IPO?- Why Companies Go Public